GENI (GENI) Stock Price & Analysis
GENI (GENI) fell 1.83% to USD 7.49 as of September 8, 2026 at 04:24 UTC, according to Nexqual real-time market data.
GENI last closed at USD 7.49; the session ranged USD 7.39–7.6 on volume of 3,137,978 shares. Market capitalization is —, with a 52-week range of USD 3.83–13.69 (NYQ). Source: Nexqual, September 8, 2026 at 04:24 UTC.
Key Statistics (as of September 8, 2026 at 04:24 UTC)
| Price | USD 7.49 |
|---|---|
| Change | ▼ 1.83% (down) |
| Previous Close | USD 7.49 |
| Open | USD 7.49 |
| Day Range | USD 7.39 – 7.6 |
| 52-Week Range | USD 3.83 – 13.69 |
| Volume | 3,137,978 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (GENI)
Nexqual's technical model rates GENI "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 04:24 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 50.45 (neutral) |
| vs SMA50 | Above (USD 7.15) |
| MACD | 0.08 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SRAD | Sportradar Group AG | USD 12.9 | ▼ 0.15% |
| RSI | Rush Street Interactive, Inc. | USD 26.68 | ▲ 1.95% |
| SRTA | Strata Critical Medical, Inc. | USD 5.32 | ▼ 1.3% |
| PSFE | Paysafe Limited | USD 6.71 | ▲ 1.36% |
| MQ | Marqeta, Inc. | USD 16.58 | ▼ 1.43% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:24 UTC. This page is informational and not investment advice.